UNSPSC 51461502: Ipecacuanha extract

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 62I3C8233L, which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 846063 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Asteranae, Order Gentianales, Family Rubiaceae, Genus Carapichea, commonly known as IPECACUANHA.

European Medicines Agency schedules cinnamomum in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB46920, SUB46936, SUB46937, SUB46938, SUB46939, SUB46940, and SUB46941.

UNSPSC 51461502 Ipecacuanha extract, a Commodity code, addresses the procurement of ipecacuanha plant extract used primarily in pharmaceutical and medical applications. State and local governments acquire this material for inclusion in over-the-counter emetic medications, poison-control formulations, and related pharmaceutical products distributed through public health agencies, hospital systems, and emergency medical services. The code spans purchases by state health departments, county public health offices, and municipal emergency response agencies that maintain stockpiles of ipecac-based treatments for acute poisoning cases, though procurement volume remains limited to specialized medical supply channels and regulated pharmaceutical distributors.

The source provides no recent state and local contract opportunities tagged to this code. Without posted solicitations or awarded contracts in the most-recent-opportunities record, no geographic concentration, issuing-body pattern, or representative RFP/RFQ activity can be identified. This absence suggests either minimal state and local procurement activity under the code or infrequent posting of opportunities in public procurement databases. Firms pursuing this commodity should monitor state health department pharmaceutical schedules and cooperative purchasing vehicles serving hospital consortia and emergency medical service networks, where episodic demand for specialized pharmaceutical extracts typically surfaces.